SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Hang Lung Properties Limited (HLPPY) trades at a trailing P/E of 3.3, forward P/E of 1.9. Trailing earnings yield is 30.67%, forward earnings yield 52.08%. PEG 0.03 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (100/100, Pass) — P/E is below market average (3.3); PEG ≤ 1.0 — Peter Lynch undervalued (0.03); earnings yield beats bond yields (30.67%).
- Forward P/E 1.9 (down from trailing 3.3) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.03 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 30.67% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income. Forward yield improves to 52.08% as earnings recover.
Overall SharesGrow Score: 70/100 with 4/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
83/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — HLPPY
Valuation Multiples
P/E (TTM)3.3
Forward P/E1.9
PEG Ratio0.03
Forward PEG0.03
P/B Ratio0.00
P/S Ratio0.60
EV/EBITDA0.0
Per Share Data
EPS (TTM)$1.85
Forward EPS (Est.)$3.14
Book Value / Share$0.00
Revenue / Share$10.11
FCF / Share$0.00
Yields & Fair Value
Earnings Yield30.67%
Forward Earnings Yield52.08%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$6.90 |
$13.06B |
$6.2B |
47.4% |
| 2017 |
$9.05 |
$11.2B |
$8.12B |
72.5% |
| 2018 |
$9.00 |
$9.41B |
$8.08B |
85.9% |
| 2019 |
$6.85 |
$8.85B |
$6.17B |
69.7% |
| 2020 |
$-2.85 |
$8.97B |
$-2.57B |
-28.7% |
| 2021 |
$4.30 |
$10.32B |
$3.87B |
37.5% |
| 2022 |
$4.25 |
$10.35B |
$3.84B |
37.1% |
| 2023 |
$4.40 |
$10.35B |
$3.97B |
38.4% |
| 2024 |
$2.40 |
$11.24B |
$2.15B |
19.2% |
| 2025 |
$1.85 |
$9.95B |
$1.8B |
18.1% |
